Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Royal Academy of Engineering has announced the finalists for the 2019 MacRobert Award, the most prestigious prize for UK engineering innovation.

Celebrating its 50th anniversary this year, the MacRobert Award is run by the Royal Academy of Engineering and recognises engineering teams that demonstrate outstanding innovation, tangible societal benefit and proven commercial success within the UK engineering sector.

The four finalists for the 2019 MacRobert Award include OrganOx (Oxford) for creating the metra, a world-first device that can keep a human donor liver functioning outside the body for up to 24 hours prior to transplant.

Earlier this year The National Institute for Health and Care Excellence (NICE) approved the use in the NHS of ex-vivo machine perfusion for preservation of livers donated for transplants. One variation of the technique, normothermic machine perfusion, was developed by University of Oxford Department of Engineering spinout OrganOx Ltd as a result of a cross-disciplinary collaboration between Professor Constantin Coussios (Institute of Biomedical Engineering) and Professor Peter Friend (Nuffield Department of Surgical Sciences).

Read more (University of Oxford website)

 

Media coverage

Oxford's OrganOx is shortlisted for MacRobert Award 2019
Mirage News, 11/06/2019

Similar stories

Congratulations to the winners of the NDS Staff Awards 2022

On 16 June, the winners of the 2022 NDS Staff Awards were announced at a departmental summer BBQ at the Cherwell Boathouse in Oxford.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2 June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Blog posts

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.